Co-Authors
This is a "connection" page, showing publications co-authored by MADELEINE DUVIC and KAREN C DWYER.
Connection Strength
0.178
-
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma. Blood. 2015 Mar 19; 125(12):1883-9.
Score: 0.126
-
Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma. Dermatol Ther. 2022 08; 35(8):e15634.
Score: 0.053